Study identifies 9 novel genes linked to gestational diabetes

The federal Countermeasures Injury Compensation Program (CICP) fielded a massive influx of claims due to the COVID-19 pandemic, according to a report from the U.S.

By ac­quir­ing Ec­co­gene’s GLP-1, As­traZeneca is bet­ting not just on the long-term po­ten­tial of the obe­si­ty drug mar­ket, but the val­ue of com­bin­ing the weight-loss